178 related articles for article (PubMed ID: 35945213)
1. Protection of Omicron sub-lineage infection against reinfection with another Omicron sub-lineage.
Chemaitelly H; Ayoub HH; Coyle P; Tang P; Yassine HM; Al-Khatib HA; Smatti MK; Hasan MR; Al-Kanaani Z; Al-Kuwari E; Jeremijenko A; Kaleeckal AH; Latif AN; Shaik RM; Abdul-Rahim HF; Nasrallah GK; Al-Kuwari MG; Butt AA; Al-Romaihi HE; Al-Thani MH; Al-Khal A; Bertollini R; Abu-Raddad LJ
Nat Commun; 2022 Aug; 13(1):4675. PubMed ID: 35945213
[TBL] [Abstract][Full Text] [Related]
2. Protection against omicron (B.1.1.529) BA.2 reinfection conferred by primary omicron BA.1 or pre-omicron SARS-CoV-2 infection among health-care workers with and without mRNA vaccination: a test-negative case-control study.
Carazo S; Skowronski DM; Brisson M; Barkati S; Sauvageau C; Brousseau N; Gilca R; Fafard J; Talbot D; Ouakki M; Gilca V; Carignan A; Deceuninck G; De Wals P; De Serres G
Lancet Infect Dis; 2023 Jan; 23(1):45-55. PubMed ID: 36152671
[TBL] [Abstract][Full Text] [Related]
3. Duration of immune protection of SARS-CoV-2 natural infection against reinfection.
Chemaitelly H; Nagelkerke N; Ayoub HH; Coyle P; Tang P; Yassine HM; Al-Khatib HA; Smatti MK; Hasan MR; Al-Kanaani Z; Al-Kuwari E; Jeremijenko A; Kaleeckal AH; Latif AN; Shaik RM; Abdul-Rahim HF; Nasrallah GK; Al-Kuwari MG; Butt AA; Al-Romaihi HE; Al-Thani MH; Al-Khal A; Bertollini R; Abu-Raddad LJ
J Travel Med; 2022 Dec; 29(8):. PubMed ID: 36179099
[TBL] [Abstract][Full Text] [Related]
4. Reinfection rate and disease severity of the BA.5 Omicron SARS-CoV-2 lineage compared to previously circulating variants of concern in the Canary Islands (Spain).
Ciuffreda L; Lorenzo-Salazar JM; García-Martínez de Artola D; Gil-Campesino H; Alcoba-Florez J; Rodríguez-Pérez H; Íñigo-Campos A; Salas-Hernández J; Rodríguez-Nuñez J; Muñoz-Barrera A; Valenzuela-Fernández A; Díez-Gil O; González-Montelongo R; Flores C
Emerg Microbes Infect; 2023 Dec; 12(1):2202281. PubMed ID: 37039029
[No Abstract] [Full Text] [Related]
5. Risk of SARS-CoV-2 reinfection by vaccination status, predominant variant and time from prior infection: a cohort study, Reggio Emilia province, Italy, February 2020 to February 2022.
Vicentini M; Venturelli F; Mancuso P; Bisaccia E; Zerbini A; Massari M; Cossarizza A; De Biasi S; Pezzotti P; Bedeschi E; Giorgi Rossi P; ;
Euro Surveill; 2023 Mar; 28(13):. PubMed ID: 36995374
[TBL] [Abstract][Full Text] [Related]
6. Impact of Reinfection with SARS-CoV-2 Omicron Variants in Previously Infected Hamsters.
Shiwa-Sudo N; Sakai Y; Iwata-Yoshikawa N; Watanabe S; Yamada S; Kuroda Y; Yamamoto T; Shirakura M; Fujisaki S; Miyazaki K; Miura H; Nagata S; Fukushi S; Maeda K; Hasegawa H; Suzuki T; Nagata N
J Virol; 2023 Jan; 97(1):e0136622. PubMed ID: 36633406
[TBL] [Abstract][Full Text] [Related]
7. [Prediction of protection probability against Omicron BA.1, BA.4 and BA.5 variants in symptomatic infections with prototype strain based on neutralization antibody levels].
Lu WY; Chen XH; Zheng N; Yu HJ
Zhonghua Yi Xue Za Zhi; 2023 May; 103(18):1429-1434. PubMed ID: 37150697
[No Abstract] [Full Text] [Related]
8. Immune response and severity of Omicron BA.5 reinfection among individuals previously infected with different SARS-CoV-2 variants.
Li L; Xie Z; Li Y; Luo M; Zhang L; Feng C; Tang G; Huang H; Hou R; Xu Y; Jia S; Shi J; Fan Q; Gan Q; Yu N; Hu F; Li Y; Lan Y; Tang X; Li F; Deng X
Front Cell Infect Microbiol; 2023; 13():1277880. PubMed ID: 38188634
[TBL] [Abstract][Full Text] [Related]
9. Hospitalisation and mortality risk of SARS-COV-2 variant omicron sub-lineage BA.2 compared to BA.1 in England.
Webster HH; Nyberg T; Sinnathamby MA; Aziz NA; Ferguson N; Seghezzo G; Blomquist PB; Bridgen J; Chand M; Groves N; Myers R; Hope R; Ashano E; Lopez-Bernal J; De Angelis D; Dabrera G; Presanis AM; Thelwall S
Nat Commun; 2022 Oct; 13(1):6053. PubMed ID: 36229438
[TBL] [Abstract][Full Text] [Related]
10. A case of SARS-CoV-2 Omicron reinfection resulting in a significant immunity boost in a paediatric patient affected by B-cell acute lymphoblastic leukemia.
Scutari R; Fox V; De Ioris MA; Fini V; Granaglia A; Costabile V; Colagrossi L; Russo C; Mastronuzzi A; Locatelli F; Perno CF; Alteri C
BMC Infect Dis; 2023 Mar; 23(1):133. PubMed ID: 36882724
[TBL] [Abstract][Full Text] [Related]
11. Protection Against the Omicron Variant Offered by Previous Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Retrospective Cohort Study.
Rothberg MB; Kim P; Shrestha NK; Kojima L; Tereshchenko LG
Clin Infect Dis; 2023 Feb; 76(3):e142-e147. PubMed ID: 35867678
[TBL] [Abstract][Full Text] [Related]
12. Immediate reinfection with Omicron variant after clearance of a previous SARS-CoV-2 infection.
Mencacci A; Gili A; Camilloni B; Bicchieraro G; Spaccapelo R; Bietta C; Stracci F
J Infect Public Health; 2022 Sep; 15(9):983-985. PubMed ID: 35963101
[TBL] [Abstract][Full Text] [Related]
13. Protective effect of previous infection and vaccination against reinfection with BA.5 Omicron subvariant: a nationwide population-based study in Japan.
Kitamura N; Otani K; Kinoshita R; Yan F; Takizawa Y; Fukushima K; Yoneoka D; Suzuki M; Kamigaki T
Lancet Reg Health West Pac; 2023 Dec; 41():100911. PubMed ID: 38223396
[TBL] [Abstract][Full Text] [Related]
14. Omicron Sub-Lineages (BA.1.1.529 + BA.*) Current Status in Ecuador.
Carrazco-Montalvo A; Herrera-Yela A; Alarcón-Vallejo D; Gutiérrez-Pallo D; Armendáriz-Castillo I; Andrade-Molina D; Muñoz-Mawyin K; Fernández-Cadena JC; Morey-León G; Usfq-Covid-Consortium ; Crn Influenza Y Ovr-Inspi ; Patiño L
Viruses; 2022 May; 14(6):. PubMed ID: 35746651
[TBL] [Abstract][Full Text] [Related]
15. History of primary-series and booster vaccination and protection against Omicron reinfection.
Chemaitelly H; Ayoub HH; Tang P; Coyle PV; Yassine HM; Al Thani AA; Al-Khatib HA; Hasan MR; Al-Kanaani Z; Al-Kuwari E; Jeremijenko A; Kaleeckal AH; Latif AN; Shaik RM; Abdul-Rahim HF; Nasrallah GK; Al-Kuwari MG; Butt AA; Al-Romaihi HE; Al-Thani MH; Al-Khal A; Bertollini R; Abu-Raddad LJ
Sci Adv; 2023 Oct; 9(40):eadh0761. PubMed ID: 37792951
[TBL] [Abstract][Full Text] [Related]
16. Previous SARS-CoV-2 infections and their impact on the protection from reinfection during the Omicron BA.5 wave - a nested case-control study among vaccinated adults in Sweden.
Kahn F; Bonander C; Moghaddassi M; Christiansen CB; Bennet L; Malmqvist U; Inghammar M; Björk J
IJID Reg; 2024 Mar; 10():235-239. PubMed ID: 38532742
[TBL] [Abstract][Full Text] [Related]
17. Risk of SARS-CoV-2 reinfection during multiple Omicron variant waves in the UK general population.
Wei J; Stoesser N; Matthews PC; Khera T; Gethings O; Diamond I; Studley R; Taylor N; Peto TEA; Walker AS; Pouwels KB; Eyre DW;
Nat Commun; 2024 Feb; 15(1):1008. PubMed ID: 38307854
[TBL] [Abstract][Full Text] [Related]
18. Protection of COVID-19 vaccination and previous infection against Omicron BA.1, BA.2 and Delta SARS-CoV-2 infections.
Andeweg SP; de Gier B; Eggink D; van den Ende C; van Maarseveen N; Ali L; Vlaemynck B; Schepers R; Hahné SJM; Reusken CBEM; de Melker HE; van den Hof S; Knol MJ
Nat Commun; 2022 Aug; 13(1):4738. PubMed ID: 35961956
[TBL] [Abstract][Full Text] [Related]
19. Pathogenicity of SARS-CoV-2 Omicron (R346K) variant in Syrian hamsters and its cross-neutralization with different variants of concern.
Mohandas S; Yadav PD; Sapkal G; Shete AM; Deshpande G; Nyayanit DA; Patil D; Kadam M; Kumar A; Mote C; Jain R
EBioMedicine; 2022 May; 79():103997. PubMed ID: 35405385
[TBL] [Abstract][Full Text] [Related]
20. Duration of mRNA vaccine protection against SARS-CoV-2 Omicron BA.1 and BA.2 subvariants in Qatar.
Chemaitelly H; Ayoub HH; AlMukdad S; Coyle P; Tang P; Yassine HM; Al-Khatib HA; Smatti MK; Hasan MR; Al-Kanaani Z; Al-Kuwari E; Jeremijenko A; Kaleeckal AH; Latif AN; Shaik RM; Abdul-Rahim HF; Nasrallah GK; Al-Kuwari MG; Butt AA; Al-Romaihi HE; Al-Thani MH; Al-Khal A; Bertollini R; Abu-Raddad LJ
Nat Commun; 2022 Jun; 13(1):3082. PubMed ID: 35654888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
